ArticlePloS one2025

Randomised, double-blind study to evaluate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A clinical trial protocol.

Shinobu Shimizu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.